Cite
MLA Citation
F. Ravandi-Kashani et al.. “P587: COVALENT-101: A PHASE 1 STUDY OF BMF-219, A NOVEL ORAL IRREVERSIBLE MENIN INHIBITOR, IN PATIENTS WITH RELAPSED/REFRACTORY ACUTE LEUKEMIA, DIFFUSE LARGE B-CELL LYMPHOMA, AND MULTIPLE MYELOMA.” HemaSphere, vol. 6, n.d., pp. 486–487. http://access.bl.uk/ark:/81055/vdc_100159757130.0x000015